Bowen Cai, Zheng Tian, Gelmann Edward P
Department of Medicine, Columbia University, Herbert Irving Comprehensive Cancer Center, New York, New York.
Department of Statistics, Columbia University, Herbert Irving Comprehensive Cancer Center, New York, New York.
Cancer Res. 2015 Jul 1;75(13):2686-98. doi: 10.1158/0008-5472.CAN-14-3387. Epub 2015 May 14.
TMPRSS2 gene rearrangements occur at DNA breaks formed during androgen receptor-mediated transcription and activate expression of ETS transcription factors at the early stages of more than half of prostate cancers. NKX3.1, a prostate tumor suppressor that accelerates the DNA repair response, binds to androgen receptor at the ERG gene breakpoint and inhibits both the juxtaposition of the TMPRSS2 and ERG gene loci and also their recombination. NKX3.1 acts by accelerating DNA repair after androgen-induced transcriptional activation. NKX3.1 influences the recruitment of proteins that promote homology-directed DNA repair. Loss of NKX3.1 favors recruitment to the ERG gene breakpoint of proteins that promote error-prone nonhomologous end-joining. Analysis of prostate cancer tissues showed that the presence of a TMPRSS2-ERG rearrangement was highly correlated with lower levels of NKX3.1 expression consistent with the role of NKX3.1 as a suppressor of the pathogenic gene rearrangement.
TMPRSS2基因重排发生在雄激素受体介导的转录过程中形成的DNA断裂处,并在超过一半的前列腺癌早期激活ETS转录因子的表达。NKX3.1是一种促进DNA修复反应的前列腺肿瘤抑制因子,它在ERG基因断点处与雄激素受体结合,抑制TMPRSS2和ERG基因位点的并列及其重组。NKX3.1通过在雄激素诱导的转录激活后加速DNA修复发挥作用。NKX3.1影响促进同源性定向DNA修复的蛋白质的募集。NKX3.1的缺失有利于促进易出错的非同源末端连接的蛋白质募集到ERG基因断点处。前列腺癌组织分析表明,TMPRSS2-ERG重排的存在与NKX3.1表达水平较低高度相关,这与NKX3.1作为致病基因重排抑制因子的作用一致。